SK-HEP cells and lentiviral vector for production of human recombinant factor VIII

Biotechnology Letters

Volumn 34, Issue 8, 2012, Pages 1435-1443

  da Rosa, Nathalia Gonsales ^a   Swiech, Kamilla ^a   Picanço Castro, Virgínia ^a   de Russo Carbolante, Elisa Maria Sousa ^a   Neto, Mario Abreu Soares ^a   de Castilho Fernandes, Andrielle ^a   Faça, Vitor Marcel ^a   Fontes, Aparecida Maria ^a   Covas, Dimas Tadeu ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Human cell line; Human factor VIII; Lentiviral vector; Microcarrier culture; Recombinant factor VIII; SK HEP cells

Indexed keywords

COAGULATION FACTOR; COMMERCIAL PRODUCTIONS; FACTOR VIII; HEMOPHILIA A; HUMAN CELL LINES; IN-VITRO; LENTIVIRAL VECTOR; MICROCARRIER CULTURE; SCALABLE SYSTEMS; SK-HEP-1;

BIOACTIVITY; CELLS; COAGULATION;

CELL CULTURE;

B DOMAIN DELETED FACTOR VIII; B-DOMAIN-DELETED FACTOR VIII; BLOOD CLOTTING FACTOR 8; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CULTURE TECHNIQUE; DISEASE MODEL; FLOW CYTOMETRY; GENE VECTOR; GENETICS; HEMOPHILIA A; HUMAN; LENTIVIRINAE; MOUSE; SURVIVAL; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL LINE; DISEASE MODELS, ANIMAL; FACTOR VIII; FLOW CYTOMETRY; GENETIC VECTORS; HEMOPHILIA A; HUMANS; LENTIVIRUS; MICE; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS;

LENTIVIRUS; MUS;

EID: 84864385027     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-012-0925-4     Document Type: Article

References (20)

1. Chen C, Fang XD, Zhu J, Wu XF, Zhang ZC, Gu JX, Wang ZY, Chi CW (1999) The gene expression of coagulation factor VIII in mammalian cell lines. Thromb Res 95: 105-115.
2. Dooriss KL, Denning G, Gangadharan B, Javazon EH, McCarty DA, Spencer HT, Doering CB (2009) Comparison of factor VIII transgenes bioengineered for improved expression in gene therapy of hemophilia A. Hum Gene Ther 20: 465-478.
3. Durocher Y, Butler M (2009) Expression systems for therapeutic glycoprotein production. Curr Opin Biotechnol 20: 700-707.
4. Garber K (2000) rFactor VIII deficit questioned. Nat Biotechnol 18: 1133.
5. Grillberger L, Kreil TR, Nasr S, Reiter M (2009) Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells. Biotechnol J 4: 186-201.
6. Heffelfinger SC, Hawkins HH, Barrish J, Taylor L, Darlington GJ (1992) SK HEP-I: a human cell line of endothelial origin. In Vitro Cell Dev Biol 28: 136-142.
7. Herlitschka SE, Schlokat U, Falkner FG, Dorner F (1998) High expression of a B-domain deleted factor VIII gene in a human hepatic cell line. J Biotechnol 61: 165-173.
8. Hoyer LW (1994) Hemophilia A. N Engl J Med 330: 38-47.
9. Lynch CM, Israel DI, Kaufman RJ, Miller AD (1993) Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production. Hum Gene Ther 4: 259-272.
10. Mei B, Chen Y, Chen J, Pan CQ, Murphy JE (2006) Expression of human coagulation factor VIII in a human hybrid cell line, HKB11. Mol Biotechnol 34: 165-178.
11. Mordenti J, Osaka G, Garcia K, Thomsen K, Licko V, Meng G (1996) Pharmacokinetics and interspecies scaling of recombinant human factor VIII. Toxicol Appl Pharmacol 136: 75-78.
12. Nishikawa M, Huang L (2001) Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 12: 861-870.
13. Picanco V, Heinz S, Bott D, Behrmann M, Covas DT, Seifried E, Tonn T (2007) Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter. Cytotherapy 9: 785-794.
14. Picanco-Castro V, Russo-Carbolante EMS, Fontes AM, Fernandes AC, Covas DT (2008) An enhancer/promoter combination strengthens the expression of blood-coagulation factor VIII in non-viral expression vectors. Genet Mol Res 7: 314-325.
15. Russo-Carbolante EMS, Picanço-Castro V, Alves DCC, Fernandes AC, Almeida-Porada G, Tonn T, Covas DT (2011) Integration pattern of HIV-1 based lentiviral vector carrying recombinant coagulation factor VIII in SK-HEP and 293T cells. Biotechnol Lett 33: 23-31.
16. Shi Q, Wilcox DA, Fahs SA, Kroner PA, Montgomery RR (2003) Expression of human factor VIII under control of the platelet-specific aIIb promoter in megakaryocytic cell line as well as storage together with VWF. Mol Genet Metab 79: 25-33.
17. Soucie JM, Evatt B, Jackson D (1998) Occurrence of hemophilia in the United States. The hemophilia surveillance system project investigators. Am J Hematol 59: 288-294.
18. Spencer HT, Denning G, Gautney RE, Dropulic B, Roy AJ, Baranyi L, Gangadharan B, Parker ET, Lollar P, Doering CB (2011) Lentiviral vector platform for production of bioengineered recombinant coagulation factor VIII. Mol Ther 19: 302-309.
19. Stonebracker SA, Brooker M, Amand RE, Farrugia A, Srivastava A (2010) A study of reported factor VIII use around the world. Haemophilia 16: 33-46.
20. Tharmalingam T, Sunley K, Butler M (2008) High yields of monomeric recombinant beta-interferon from macroporous microcarrier cultures under hypothermic conditions. Biotechnol Prog 24: 832-838.